Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind, Active-controlled, Multicenter Phase 3 Trial to Evaluate the Safety and Efficacy of YH14755 in Subjects With Dyslipidemia and Type II Diabetes

NCT02586129 is registered in ClinicalTrials.gov with Yuhan Corporation as lead sponsor.

NCT NCT02586129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02586129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind, Active-controlled, Multicenter Phase 3 Trial to Evaluate the Safety and Efficacy of YH14755 in Subjects With Dyslipidemia and Type II Diabetes
Lead sponsor
Yuhan Corporation
Phase
Phase 3
Overall status
Completed
Start date
November 4, 2015
Completion date
July 7, 2017
Enrollment
249 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemia, type ii diabetes